S3 (Entopharm)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameS3 (Entopharm)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs > AntibioticsBiologics > Protein drugs > Recombinant polypeptideNatural product/Extract

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsCommunicable Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEntopharm

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEntopharm

Active IndicationsN/A

Inactive IndicationsCommunicable Diseases

ATC CodeN/A